Published • loading... • Updated
AstraZeneca Adds New Breast Cancer Drug to 340B CP Restrictions
Summary by 340breport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AstraZeneca Adds New Breast Cancer Drug to 340B CP Restrictions
A U.K.-based drugmaker recently announced that its 340B contract pharmacy restrictions will soon apply to Etcamah, a metastatic breast cancer drug which A U.K.-based drugmaker recently announced that its 340B contract pharmacy restrictions will soon apply to Etcamah, a metastatic breast cancer drug which the FDA approved last month.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
